COORDINATION OF INTERNAL HEMODYNAMIC DISORDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE OF DIABETIC GENESIS BY USING 2ND TYPE SODIUM-GLUCOSE COTRANSPORTER INHIBITORS
Keywords:
diabetic nephropathy, glomerular filtration, maximum systolic, end diastolic, speed, resistance index.Abstract
The article presents the results of the research on the alternative treatment of intrarenal hemodynamic disorders with the use of type 2 sodium-glucose cotransporter inhibitors in 103 patients with chronic kidney disease developed on the basis of diabetic nephropathy. Also, comparing the obtained results with the results of other authors' researches, the nephroprotective effect of the drug is once again based in detail.
References
Bagriy A.E., Khomenko M.V., Shverova O.I., Titievskaya A.I. Approaches to the treatment of diabetic nephropathy (literature review). Nephrology. 2021; 25(1):18-30. https://doi.org/10.36485/ 1561-6274-2021-25-1-18-30
Gajonova V.E., Zykova A.S., Chistyakov A.A., Roschupkina S.V., Romanova M.D., Krasnova T.N. Prognostic significance of the renal vascular resistance index in evaluating the progression of chronic kidney disease. Therapeutic Archive. 2015;87(6):29-33.
Gajpov A.E., Nogaybaeva A.T., Aitmetova K.S., Mirzaev P.M. Evaluation of renal hemodynamic reserve in patients with chronic kidney disease using ultrasound Doppler and pharmacological testing. Clinical Medicine of Kazakhstan. 2013. No. 1 (27). P. 11-19.
Glazun L.O., Polukhina E.V. "Ultrasound Diagnosis of Kidney Diseases." Guidebook. Moscow, 2014. P. 296.
Korbut A.I., Klimontov V.V. Empagliflozin: A New Strategy for Nephroprotection in Diabetes. Diabetes. 2017;20(1):75-84. doi: 10.14341/DM8005.
Kumakura S., Okamoto K., Takeuchi S., Yoshida M., Nakamichi T., Nagasawa T., Fujikura E., Yamamoto T., Saito M., Hanita T., Satoh M., Sato H., Ito S., Harigae H., Miyazaki M. Kidney function, blood pressure, and proteinuria were associated with pregnancy outcomes of pregnant women with chronic kidney disease: A single-center, retrospective study in the Asian population. Clin Exp Nephrol. 2020;24(6):547-556. https://doi.org/10.1007/s10157-020-01865-0.
KDIGO: Chronic Kidney Disease, 2013. Clinical Practice Guidelines. Available at: CKD_GL.pdf. Accessed March 14, 2014. http://www.kdigo.org/clinical_practice_guidelines/pdf/.
Maryanova T.A., Chechneva M.A., Prokopenko E.I., Nikolskaya I.G., Chumarnaya T.V., Klimova I.V., Gubina D.V. Dopplerometric indicators of renal arterial flow in pregnant women with chronic kidney disease as early markers of kidney dysfunction. Russian Journal of Obstetrics and Gynecology. 2023;23(5):93-99.
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Kudaibergenova I.O., Murkamilova Z.A., Yusupov F.A. Diabetic nephropathy: Prevalence and risk factors. Bulletin of VolgGMU. 2021; No. 1 (77): 3–11. DOI: 10.19163/1994-9480-2021-1(77)-3-11.
Piccoli G.B., Zakharova E., Attini R., Hernandez M.I., Guillien A.O., Alrukhaimi M., Liu Z-H., Ashuntantang G., Covella B., Cabiddu G., Li P.K.T., Garcia-Garcia G., Levin A. Pregnancy in chronic kidney disease: Need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases. J Clin Med. 2018;7(11):415. https://doi.org/ 10.3390/jcm7110415.
Skrtic M., Cherney D.Z. Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy. Curr Opin Nephrol Hypertens. 2015;24(1):96-103. doi: 10.1097/MNH.0000000000000084.
Sultanov N.N., Barnoev K.B., Toshpulatova M.Kh., Narzikulova M.Sh., Maksudova L.I. Antiplatelet therapy: Its effect on kidney function in patients with chronic kidney disease. Monthly International Scientific Journal "AUSRIA-SCIENCE". 2020:23-25.
